278 related articles for article (PubMed ID: 20411168)
1. Evaluation of the gamma probe guided sentinel lymph node biopsy and the blue dye technique in the management of breast cancer.
Usmani S; Khan HA; abu Huda F; Ahmed N; al Nafisi N; Marafi F; al Mohannadi S; Javed A; Amanguno HG; Al Saleh N
Hell J Nucl Med; 2010; 13(1):30-4. PubMed ID: 20411168
[TBL] [Abstract][Full Text] [Related]
2. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
[TBL] [Abstract][Full Text] [Related]
3. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
[TBL] [Abstract][Full Text] [Related]
4. Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes.
Lin KM; Patel TH; Ray A; Ota M; Jacobs L; Kuvshinoff B; Chung M; Watson M; Ota DM
J Am Coll Surg; 2004 Oct; 199(4):561-6. PubMed ID: 15454139
[TBL] [Abstract][Full Text] [Related]
5. ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer.
Hirche C; Murawa D; Mohr Z; Kneif S; Hünerbein M
Breast Cancer Res Treat; 2010 Jun; 121(2):373-8. PubMed ID: 20140704
[TBL] [Abstract][Full Text] [Related]
6. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.
Kargozaran H; Shah M; Li Y; Beckett L; Gandour-Edwards R; Schneider PD; Khatri VP
J Surg Res; 2007 Nov; 143(1):126-9. PubMed ID: 17950081
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma.
Shimazu K; Tamaki Y; Taguchi T; Akazawa K; Inoue T; Noguchi S
Cancer; 2004 Jun; 100(12):2555-61. PubMed ID: 15197796
[TBL] [Abstract][Full Text] [Related]
9. Added value of blue dye in sentinel node biopsy for breast cancer.
Snoj M; Golouh R; Movrin-Stanovnik T; Vidergar-Kralj B
J Exp Clin Cancer Res; 2003 Dec; 22(4):551-5. PubMed ID: 15053296
[TBL] [Abstract][Full Text] [Related]
10. Is blue dye indicated for sentinel lymph node biopsy in breast cancer patients with a positive lymphoscintigram?
Degnim AC; Oh K; Cimmino VM; Diehl KM; Chang AE; Newman LA; Sabel MS
Ann Surg Oncol; 2005 Sep; 12(9):712-7. PubMed ID: 16079955
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node scintigraphy and radioguided dissection in breast carcinoma: an initial experience at Aga Khan University Hospital.
Zaman MU; Khan S; Hussain R; Ahmed MN
J Pak Med Assoc; 2006 Apr; 56(4):153-6. PubMed ID: 16711334
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
13. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
[TBL] [Abstract][Full Text] [Related]
14. The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers.
Tousimis E; Van Zee KJ; Fey JV; Hoque LW; Tan LK; Cody HS; Borgen PI; Montgomery LL
J Am Coll Surg; 2003 Oct; 197(4):529-35. PubMed ID: 14522317
[TBL] [Abstract][Full Text] [Related]
15. The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node.
Argon AM; Duygun U; Acar E; Daglioz G; Yenjay L; Zekioglu O; Kapkac M
Clin Nucl Med; 2006 Dec; 31(12):795-800. PubMed ID: 17117076
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of sentinel lymph node biopsy using methylene blue dye in clinically node-negative papillary thyroid carcinoma.
Ji YB; Lee KJ; Park YS; Hong SM; Paik SS; Tae K
Ann Surg Oncol; 2012 Jun; 19(6):1868-73. PubMed ID: 21989668
[TBL] [Abstract][Full Text] [Related]
17. [An initial experience of the use of sentinel lymph node biopsy in squamous cell cancer of the vulva].
Li B; Wu LY; Liu L; Zhang R; Zhang GY; Yu GZ
Zhonghua Fu Chan Ke Za Zhi; 2009 May; 44(5):364-8. PubMed ID: 19573313
[TBL] [Abstract][Full Text] [Related]
18. The clinical utility of combining pre-operative axillary ultrasonography and fine needle aspiration cytology with radionuclide guided sentinel lymph node biopsy in breast cancer patients with palpable axillary lymph nodes.
Usmani S; Ahmed N; Al Saleh N; abu Huda F; Amanguno HG; Amir T; al Kandari F
Eur J Radiol; 2015 Dec; 84(12):2515-20. PubMed ID: 26474908
[TBL] [Abstract][Full Text] [Related]
19. Selective approach to radionuclide-guided sentinel lymph node biopsy in high-risk ductal carcinoma in situ of the breast.
Usmani S; Khan HA; Al Saleh N; abu Huda F; Marafi F; Amanguno HG; Al Nafisi N; Al Kandari F
Nucl Med Commun; 2011 Nov; 32(11):1084-7. PubMed ID: 21862942
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy.
Albo D; Ames FC; Hunt KK; Ross MI; Singletary SE; Kuerer HM
Breast Cancer Res Treat; 2003 Jan; 77(1):9-14. PubMed ID: 12602900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
